Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion type Assertion NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_head.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion description "[In contrast, the non-glial tumors displayed an overall aberrant MGMT promoter methylation of 26%, even though this group includes highly malignant tumors such as neuroblastomas, medulloblastomas and brain metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_provenance.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion evidence source_evidence_literature NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_provenance.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion SIO_000772 15450401 NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_provenance.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion wasDerivedFrom befree-20150227 NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_provenance.
- NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_assertion wasGeneratedBy ECO_0000203 NP555486.RA21238qZ_lttQ9F2-C7wRWFrWRdpsYjE8XTD3UA-cN9c130_provenance.